South and Central America Cardiac Rehabilitation Market Key Players and Forecast by 2028

South and Central America Cardiac Rehabilitation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Heart Rate Monitor, Stabilization Balls, Treadmill, Rower, Elliptical Trainer, Blood Pressure Monitor, Stationary Bicycle, and Others), Application (Angioplasty, Coronary Artery Disease, Cardiomyopathy, Cholesterol Management, Diabetes, and Lung Transplant), and End User (Hospitals and Clinics, Specialty Hospitals, Home Healthcare, Cardiac Rehabilitation Centers, and Others)

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028
  • Status : Published
  • Report Code : TIPRE00023032
  • Category : Life Sciences
  • No. of Pages : 125
  • Available Report Formats : pdf-format excel-format
  • Last update date : June 09, 2021
South and Central America Cardiac Rehabilitation Market Key Players and Forecast by 2028
Report Date: June 09, 2021   |   Report Code: TIPRE00023032 Email: sales@theinsightpartners.com

2021 Market Size

US$ 125.17 Mn

Base year value

2028 Forecast

US$ 171.93 Mn

Projected by 2028

CAGR 2022-2028

4.6 %

Growth rate

Addressable Market

US$ 1,053.13 Mn

(2022-2028)

The South and Central America cardiac rehabilitation market is expected to reach US$ 171.93 million by 2028 from US$ 125.17 million in 2021; it is estimated to grow with a CAGR of 4.6% from 2021 to 2028.

The growth of the market is attributed to key driving factors such as rising incidences of cardiovascular diseases, and growing adoption of tele-cardiac rehabilitation. However, the high cost of the cardiac rehabilitation equipment is expected to obstruct the growth of the market to a certain extent during the forecast years.

Cardiac rehabilitation devices are used by patients suffering from heart diseases. These rehabilitation devices aid the patients in reducing the danger of heart attacks and heart diseases. In the last few decades, a few risk factors for cardiovascular diseases (CVDs) have improved, while others have worsened. At the same time, Americans’ average body mass index and prevalence of diabetes have augmented as the population continues to have made the CVD more prevalent. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also rising. Heart disease has endured an important cause of death in Latin America for the past 20 years. The global patterns of total CVD have significant consequences for clinical practice and public health policy development. Therefore, a substantial increase in cardiovascular diseases is anticipated to positively influence the market growth during the forecast period. The breakthrough technologies such as e-cardiology and e-health have evolved considerably over the past years and are anticipated to impact CVD management and prevention. Also, tele-cardiac rehabilitation probably decreases barriers of distance, time, and cost. The family members of cardiac patients found telerehabilitation technologies a valuable digital toolbox in the rehabilitation process. Therefore, the significant growing adoption of tele-cardiac rehabilitation in the healthcare sector is anticipated to positively influence market growth during the forecast period.

The outbreak of COVID–19 has severely impacted the flow of medical services in the region. Also, the countries are popular for medical tourism, which is also affected by the pandemic. It is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the region. Moreover, countries are significantly dependent on the US and European countries for their medical resources which are under strict trade restrictions. Thus, the South and central America cardiac rehabilitation market has experienced a significant slowdown and is expected to face the same in the following two to three years.
South and central America cardiac rehabilitation market

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

SOUTH AND CENTRAL AMERICA CARDIAC REHABILITATION MARKET SEGMENTATION

By Product

  • Treadmill
  • Elliptical Trainer
  • Stationary Bicycle
  • Blood Pressure Monitor
  • Rower
  • Heart Rate Monitor
  • Stabilization Balls
  • Others

By Application

  • Angioplasty
  • Coronary Artery Disease
  • Cardiomyopathy
  • Cholesterol Management
  • Diabetes
  • Lung Transplant

By End User

  • Cardiac Rehabilitation Centers
  • Home Healthcare
  • Specialty Hospitals
  • Hospitals & Clinics
  • Others

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

  • OMRON Corporation
  • Koninklijke Philips N.V
  • General Electric Company
  • Core Health & Fitness, LLC
  • Resideo Technologies, Inc

South and Central America Cardiac Rehabilitation Report Scope

Report Attribute Details
Market size in 2021 US$ 125.17 Million
Market Size by 2028 US$ 171.93 Million
CAGR (2021 - 2028) 4.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Heart Rate Monitor
  • Stabilization Balls
  • Treadmill
  • Rower
  • Elliptical Trainer
  • Blood Pressure Monitor
  • Stationary Bicycle
By Application
  • Angioplasty
  • Coronary Artery Disease
  • Cardiomyopathy
  • Cholesterol Management
  • Diabetes
  • Lung Transplant
By End User
  • Hospitals and Clinics
  • Specialty Hospitals
  • Home Healthcare
  • Cardiac Rehabilitation Centers
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • OMRON Corporation
  • Koninklijke Philips N.V
  • General Electric Company
  • Core Health & Fitness, LLC
  • Resideo Technologies, Inc
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA